Regeneron Surrenders Most Early Gains After Q3 Beat
November 08, 2017 at 14:29 PM EST
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) shares are trading higher by $1.50 at $405.89 in Wednesday's session. Before the open, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.